Using Popsicles to Manage Taste Changes During Prostate Cancer Chemotherapy

This clinical trial explores an innovative approach to help prostate cancer patients manage taste alterations that commonly occur during taxane chemotherapy. The study specifically investigates whether using simple popsicles as a form of oral cryotherapy can reduce or prevent the unpleasant taste changes many patients experience during cancer treatment.

The research focuses on men with prostate cancer who are beginning their first cycle of single-agent taxane chemotherapy and haven't previously received chemotherapy treatment. Participants must be at least 18 years old, English-speaking, and have good overall health status. The study excludes patients who already have existing taste problems, oral surgeries, or mouth abnormalities that might interfere with the treatment, as well as those receiving oxaliplatin chemotherapy, which causes sensitivity to cold substances.

In this carefully designed study, 60 participants will be randomly assigned to one of two groups. The experimental group will use popsicles as oral cryotherapy during their chemotherapy sessions, following a specific protocol: they'll suck on popsicles for 5 minutes before chemotherapy begins, continue throughout the 75-minute infusion, and for 10 minutes after the treatment completes. The control group will receive standard care and will be asked to avoid ice or popsicles during their treatment cycle. Both groups will complete surveys about their taste experiences and undergo taste perception testing.

The primary goal is to measure changes in taste alterations using the Chemotherapy-induced Taste Alteration Scale (CiTAS). Researchers will compare scores taken before treatment begins and just before the second chemotherapy cycle starts (typically 21 days later). Additionally, the study will assess changes in basic taste perception using taste strips that evaluate the ability to detect salty, sour, bitter, sweet, and umami flavors. The double-blind, randomized design ensures that neither patients nor researchers know which treatment group participants are in, which helps eliminate bias in the results.

Taste alterations represent one of the most challenging side effects of cancer treatment, significantly impacting patients' quality of life and nutritional status. When food tastes metallic, bland, or otherwise unpleasant, patients often experience reduced appetite, weight loss, and decreased enjoyment of meals and social eating experiences. This can lead to malnutrition, treatment delays, and emotional distress during an already difficult time. The importance of research in this area cannot be overstated, as effective management of taste changes can dramatically improve patients' quality of life and treatment outcomes.

What makes this study particularly promising is its focus on a simple, inexpensive, and non-invasive intervention that patients can easily incorporate into their treatment routine. Unlike medications that may cause additional side effects, oral cryotherapy using popsicles represents a natural approach that leverages the body's physiological responses to cold. The cooling effect may help protect taste buds and reduce chemotherapy's impact on taste perception by constricting blood vessels in the mouth, potentially limiting exposure to the chemotherapy drugs.

This research, conducted at City of Hope Medical Center with collaboration from the National Cancer Institute, represents an important step toward improving supportive care for cancer patients. If successful, the findings could provide healthcare providers with evidence-based guidance for managing taste alterations, potentially benefiting thousands of patients undergoing chemotherapy each year. The study's focus on patient-centered outcomes acknowledges that cancer treatment involves not just fighting the disease but maintaining quality of life throughout the journey.

Beyond the immediate benefits for prostate cancer patients, this research could have broader implications for other cancer types and chemotherapy regimens. The simple nature of the intervention means it could be easily adopted across various healthcare settings, from major cancer centers to community hospitals. Furthermore, understanding the mechanisms behind oral cryotherapy's effects could lead to improved versions of the technique or combination approaches with other supportive care measures.

The researchers' comprehensive approach to measuring outcomes—combining validated survey instruments with objective taste testing—ensures that the results will provide a complete picture of the intervention's effectiveness. The inclusion of follow-up assessments before the second treatment cycle allows researchers to determine whether the benefits persist beyond the immediate treatment period. This longitudinal aspect is crucial for understanding the real-world utility of the intervention in clinical practice.

For patients and caregivers, this research offers hope that the challenging side effects of cancer treatment may become more manageable through simple, accessible interventions. The study demonstrates the ongoing commitment of cancer researchers to not only develop more effective treatments but also to improve the patient experience throughout the cancer journey. As cancer treatments continue to advance, supportive care research like this plays an equally important role in ensuring patients can maintain their quality of life while fighting their disease.